INO-1401

N/A

Report date: 2024/07/04 20:00:24

Base Information

Drug NameINO-1401
Drug Alias NameSynCon TERTSynthetic consensus TERT DNA vaccineINO-1401
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsOvarian Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsHead and Neck NeoplasmsOvarian Neoplasms +[9] 

Other Information

ATC CodeN/A
Related LinksN/A